3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Thoracic
2
Conditions
Colonic Neoplasms
4
Stomach Neoplasms
3
Colorectal Neoplasms
3
Lymphatic Metastasis
2
Lung Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stage IV or Unresectable Gastric Cancer
1
Pilonidal Sinus
1
Pancreatic Neuroendocrine Tumors
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pain
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Malignant Neoplasm of Transverse Colon
1
Locally Advanced Gastric Cancer
1
Kidney Neoplasms
1
Endometrial Neoplasms
1
Colorectal Liver Metastasis
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
339
Cisplatin
238
Paclitaxel
203
Radiotherapy
194
Pemetrexed
187
Docetaxel
169
Gemcitabine
157
pembrolizumab
140
Erlotinib Hydrochloride
107
Etoposide
98
Magnetic Resonance Spectroscopy
92
Bevacizumab
91
Specimen Handling
76
Nivolumab
73
Radiosurgery
71
durvalumab
69
Vinorelbine
54
osimertinib
53
Gefitinib
49
Drug Therapy
49
Irinotecan
42
atezolizumab
41
Topotecan
39
Radiation
39
Biopsy
39
Cyclophosphamide
38
Standard of Care
37
Cetuximab
35
Blood Specimen Collection
33
Taxes
32
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Lung Neoplasms
×
Conversion to Open Surgery
×
Clear all
NCT04009915
2022-05-09
VOLCANO
Shanghai Pulmonary Hospital, Shanghai, China
Phase 3
Unknown
200 enrolled
NCT03521375
2020-09-22
VIOLET
University of Bristol
Phase NA
Completed
503 enrolled